相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The PD-1/PD-L1 axis contributes to immune metabolic dysfunctions of monocytes in chronic lymphocytic leukemia
M. Qorraj et al.
LEUKEMIA (2017)
Integrins and Cell Metabolism: An Intimate Relationship Impacting Cancer
Rehman Ata et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
The clinical significance and underlying correlation of pStat-3 and integrin αvβ6 expression in gallbladder cancer
Liu Enyu et al.
ONCOTARGET (2017)
The significance of programmed cell death ligand 1 expression in resected lung adenocarcinoma
Shafei Wu et al.
ONCOTARGET (2017)
Nanoparticles Coated with Neutrophil Membranes Can Effectively Treat Cancer Metastasis
Ting Kang et al.
ACS NANO (2017)
Frequent PD-L1 expression in primary and metastatic penile squamous cell carcinoma: potential opportunities for immunotherapeutic approaches
A. M. Udager et al.
ANNALS OF ONCOLOGY (2016)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma
Curtis A. Clark et al.
CANCER RESEARCH (2016)
FBW7 (F-box andWDRepeat Domain-Containing 7) Negatively Regulates Glucose Metabolism by Targeting the c-Myc/TXNIP (Thioredoxin-Binding Protein) Axis in Pancreatic Cancer
Shunrong Ji et al.
CLINICAL CANCER RESEARCH (2016)
MYC regulates the antitumor immune response through CD47 and PD-L1
Stephanie C. Casey et al.
SCIENCE (2016)
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
Weiping Zou et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
The role of PD-L1 in the radiation response and prognosis for esophageal squamous cell carcinoma related to IL-6 and T-cell immunosuppression
Miao-Fen Chen et al.
ONCOTARGET (2016)
Bufalin enhances antitumor effect of paclitaxel on cervical tumorigenesis via inhibiting the integrin α2/β5/FAK signaling pathway
Fei Liu et al.
ONCOTARGET (2016)
Prognostic value of the Hippo pathway transcriptional coactivators YAP/TAZ and β1-integrin in conventional osteosarcoma
Corinne Bouvier et al.
ONCOTARGET (2016)
Programmed death-ligand 1 overexpression is a prognostic marker for aggressive papillary thyroid cancer and its variants
Subrata Chowdhury et al.
ONCOTARGET (2016)
Genetic Basis for PD-L1 Expression in Squamous Cell Carcinomas of the Cervix and Vulva
Brooke E. Howitt et al.
JAMA ONCOLOGY (2016)
Recent Insight into the Role of the PD-1/PD-L1 Pathway in Feto-Maternal Tolerance and Pregnancy
Yong-Hong Zhang et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2015)
IL10 and PD-1 Cooperate to Limit the Activity of Tumor-Specific CD8+ T Cells
Z. Sun et al.
CANCER RESEARCH (2015)
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chih-Hao Chang et al.
CELL (2015)
α5β1 integrin recycling promotes Arp2/3-independent cancer cell invasion via the formin FHOD3
Nikki R. Paul et al.
JOURNAL OF CELL BIOLOGY (2015)
PD-L1 induces epithelial-to-mesenchymal transition via activating SREBP-1c in renal cell carcinoma
Yiwei Wang et al.
MEDICAL ONCOLOGY (2015)
Tumour exosome integrins determine organotropic metastasis
Ayuko Hoshino et al.
NATURE (2015)
Sentinel lymph node metastases in cancer: Causes, detection and their role in disease progression
S. D. Nathanson et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2015)
Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance
Laetitia Seguin et al.
TRENDS IN CELL BIOLOGY (2015)
High PD-L1 expression was associated with poor prognosis in 870 Chinese patients with breast cancer
Tao Qin et al.
ONCOTARGET (2015)
Fibrillin-1, induced by Aurora-A but inhibited by BRCA2, promotes ovarian cancer metastasis
Ziliang Wang et al.
ONCOTARGET (2015)
Nodal metastasis in cervical cancer occurs in clearly delineated fields of immune suppression in the pelvic lymph catchment area
A. Marijne Heeren et al.
ONCOTARGET (2015)
PD-L1 and Survival in Solid Tumors: A Meta-Analysis
Pin Wu et al.
PLOS ONE (2015)
High and Interrelated Rates of PD-L1(+)CD14(+) Antigen-Presenting Cells and Regulatory T Cells Mark the Microenvironment of Metastatic Lymph Nodes from Patients with Cervical Cancer
A. Marijne Heeren et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Micrometastatic Cancer Cells in Lymph Nodes, Bone Marrow, and Blood Clinical Significance and Biologic Implications
Stanley P. L. Leong et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
The PD-1/PD-Ls pathway and autoimmune diseases
Suya Dai et al.
CELLULAR IMMUNOLOGY (2014)
PD-L1 is a novel direct target of HIF-1α., and its blockade under hypoxia enhanced MDSC-mediated T cell activation
Muhammad Zaeem Noman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
SIRT3 Controls Cancer Metabolic Reprogramming by Regulating ROS and HIF
Paul T. Schumacker
CANCER CELL (2011)
SIRT3 Opposes Reprogramming of Cancer Cell Metabolism through HIF1α Destabilization
Lydia W. S. Finley et al.
CANCER CELL (2011)
B7-H1 Overexpression Regulates Epithelial-Mesenchymal Transition and Accelerates Carcinogenesis in Skin
Yujia Cao et al.
CANCER RESEARCH (2011)
SIRT3 Is a Mitochondria-Localized Tumor Suppressor Required for Maintenance of Mitochondrial Integrity and Metabolism during Stress
Hyun-Seok Kim et al.
CANCER CELL (2010)
Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling
Eric Verdin et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
Genetic, Immunologic, and Immunohistochemical Analysis of the Programmed Death 1/Programmed Death Ligand 1 Pathway in Human Systemic Lupus Erythematosus
George K. Bertsias et al.
ARTHRITIS AND RHEUMATISM (2009)
Overexpression of PD-L1 Significantly Associates with Tumor Aggressiveness and Postoperative Recurrence in Human Hepatocellular Carcinoma
Qiang Gao et al.
CLINICAL CANCER RESEARCH (2009)
PD-1 and its ligands in tolerance and immunity
Mary E. Keir et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
PD-1 ligands expressed on myeloid-derived APC in the CNS regulate T-cell responses in EAE
Bettina Schreiner et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Long-term outcome and prognostic factors in patients with cervical carcinoma: a retrospective study
I. L. Atahan et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2007)
β4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis
Wenjun Guo et al.
CELL (2006)
PD-1 ligands, negative regulators for activation of naive, memory, and recently activated human CD4+ T cells
GF Cai et al.
CELLULAR IMMUNOLOGY (2004)
分享论文
